About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Pipeline
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Chronic Idiopathic Constipation
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Pipeline
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Chronic Idiopathic Constipation
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
Publications
Disease Area
Hyperphosphatemia
IBS-C
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Filter
2025
The Role of Serum Phosphate Control in Supporting Transplant Readiness in Patients on Dialysis
Current Medical Research and Opinion
The Positive Impact of Patient Education on Tenapanor Adherence in the OPTIMIZE Study
Nephrology Nursing Journal
A Randomized Pilot Study to Evaluate the Stability, Taste, and Palatability of a Novel Liquid Formulation of Tenapanor
Drug Development and Industrial Pharmacy
Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3)
Clinical and Experimental Gastroenterology
Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients with Kidney Failure
Journal of Renal Nutrition
Pages:
1
2
3
4
5
6
7
8
9
Load More
Sorry, nothing found in this query